The use of CPAP in patients with refractory epilepsy

被引:18
|
作者
Beran, RG [1 ]
Holland, GJ [1 ]
Yan, KY [1 ]
机构
[1] ST LUKES HOSP,TELEMETRY & SLEEP CTR,POTTS POINT,NSW 2011,AUSTRALIA
关键词
management; sleep apnoea; epilepsy; treatment; polysomnograph; diagnosis;
D O I
10.1016/S1059-1311(97)80081-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Four patients, diagnosed with refractory epilepsy, were treated with both continuous positive airway pressure (CPAP) and antiepileptic medication (AEM) and showed >50% reduction in seizures after 6 months-2 years follow-up. Two patients subsequently had AEM withdrawn and are seizure free and in one such patient, obstructive sleep apnoea (OSA) has remained the only operative diagnosis. This dual approach to care provided a real advantage to the management of patients with the dual diagnoses of OSA and epilepsy, which was refractory to standard AEM therapy.
引用
收藏
页码:323 / 325
页数:3
相关论文
共 50 条
  • [1] Characteristics of refractory vs. medically controlled epilepsy patients with obstructive sleep apnea and their response to CPAP treatment
    Li, Ping
    Ghadersohi, Saied
    Jafari, Behrouz
    Teter, Barbara
    Sazgar, Mona
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2012, 21 (09): : 717 - 721
  • [2] Refractory epilepsy in glioma patients
    Glass, Jon
    Ko, James
    NEURO-ONCOLOGY, 2007, 9 (04) : 567 - 567
  • [3] CELONTIN IN PATIENTS WITH REFRACTORY EPILEPSY
    DOW, RS
    MACFARLANE, JP
    STEVENS, JR
    NEUROLOGY, 1958, 8 (03) : 201 - 204
  • [4] CPAP adherence in epilepsy patients with obstructive sleep apnea
    Weatherwax, KJ
    Chervin, RD
    Wedal, R
    Selwa, LM
    Foldvary-Schaefer, N
    Vaughn, BV
    Malow, BA
    SLEEP, 2005, 28 : A163 - A163
  • [5] CPAP - A treatment for epilepsy?
    Benbadis, Selim R.
    Liu, Lynn
    NEUROLOGY, 2007, 69 (19) : 1814 - 1815
  • [6] EFFECTIVENESS OF THE USE OF AN OMEGA 3/6 COMBINATION IN PAEDIATRIC PATIENTS WITH REFRACTORY EPILEPSY
    Barragan Perez, E. J.
    Huerta Albarran, R.
    Heredia Barragan, I.
    EPILEPSIA, 2012, 53 : 157 - 157
  • [7] Patterns of antiepileptic drug use in patients with potential refractory epilepsy in Texas Medicaid
    Gupte-Singh, Komal
    Wilson, James P.
    Barner, Jamie C.
    Richards, Kristin M.
    Rascati, Karen L.
    Hovinga, Collin
    EPILEPSY & BEHAVIOR, 2018, 87 : 108 - 116
  • [8] Use of verapamil as a potential P-glycoprotein inhibitor in patients with refractory epilepsy
    McAuley, JW
    Summers, MA
    Moore, JL
    Long, L
    Shneker, BF
    EPILEPSIA, 2004, 45 : 124 - 125
  • [9] Pharmacokinetic variability and use of therapeutic drug monitoring of cannabidiol in patients with refractory epilepsy
    Johannessen Landmark, Cecilie
    Saetre, Johan
    Gottas, Andre
    Wolden, Martha
    Mcquade, Tao Angell-Petersen
    Kjeldsen, Signe Flood
    Vatevik, Anne
    Saetre, Erik
    Svendsen, Torleiv
    Burns, Margrete Larsen
    Oiestad, Elisabeth Leere
    Johannessen, Svein I.
    EPILEPSIA, 2025,
  • [10] Adjunctive use of verapamil in patients with refractory temporal lobe epilepsy: A pilot study
    Asadi-Pooya, Ali A.
    Razavizadegan, S. Mohammad Ali
    Abdi-Ardekani, Alireza
    Sperling, Michael R.
    EPILEPSY & BEHAVIOR, 2013, 29 (01) : 150 - 154